Follow the ProSomnus, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 16 February 2024 (Attribution). Among the most active insiders: Dow Brian B. The full history is free.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ProSomnus, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental score
Ranked 24,692 of 29,024 companies
26.7
score / 100
Value
23
Quality
31
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn37%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ProSomnus, Inc. is a company focused on developing solutions for sleep disorders. It specializes in designing medical devices to enhance patients' sleep quality.